Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 39.31%
March 31, 2026 -58.87%
December 31, 2025 -24.88%
September 30, 2025 3.68%
June 30, 2025 -0.84%
March 31, 2025 -126.6%
December 31, 2024 41.56%
September 30, 2024 -18.58%
June 30, 2024 -234.9%
March 31, 2024 5.65%
December 31, 2023 -0.51%
September 30, 2023 -39.29%
June 30, 2023 -48.53%
March 31, 2023 9.01%
December 31, 2022 -33.77%
September 30, 2022 23.35%
June 30, 2022 -25.40%
March 31, 2022 17.02%
December 31, 2021 35.19%
September 30, 2021 17.94%
June 30, 2021 25.09%
March 31, 2021 35.86%
December 31, 2020 37.40%
September 30, 2020 41.16%
June 30, 2020 32.54%
Date Value
March 31, 2020 2.88%
December 31, 2019 14.74%
September 30, 2019 8.80%
June 30, 2019 4.08%
March 31, 2019 -1.63%
December 31, 2018 -1.81%
September 30, 2018 -0.64%
June 30, 2018 -12.68%
March 31, 2018 -2.34%
December 31, 2017 -11.88%
September 30, 2017 -0.64%
June 30, 2017 -17.65%
March 31, 2017 -17.19%
December 31, 2016 -26.35%
September 30, 2016 -1.42%
June 30, 2016 -8.67%
March 31, 2016 -15.86%
December 31, 2015 19.24%
September 30, 2015 -2.69%
June 30, 2015 95.88%
March 31, 2015 -15.28%
December 31, 2014 6.55%
September 30, 2014 3.41%
June 30, 2014 -20.21%
March 31, 2014 -33.75%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 7.37%
AngioDynamics, Inc. -8.77%
Alphatec Holdings, Inc. -12.07%
AtriCure, Inc. 5.83%
Baxter International, Inc. 4.56%